SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy-Related Cardiac Dysfunction
Related Posts
Chatterjee P, Canale V, King SJ, Shawki A, Lei H, Santos AN, Haddad M, Gries C, McGovern DPB, Borneman J, McCole DF. The PTPN2 rs1893217 IBD risk[...]
Eriksson SE, Kolb JM, Nguyen J, Sarici IS, Zheng P, Ayazi S. Distal esophageal acid exposure and poor esophageal clearance correlate with probability of progression[...]
Pathipati MP, Shortt A, Shortt C, McBride B, O'Rourke L, Burke R, Chey WD, Chang L, Staller K. Impact of Short Duration FODMAP Restriction on[...]